When does semaglutide’s patent expire in Mexico?
I can’t determine a specific “semaglutide patent expiry date in Mexico” from the information provided here. Patent expiry depends on the exact patent(s) covering the relevant formulation and use (for example, the original molecule patent versus later patents on specific forms, dosing regimens, or combinations), and those dates can differ.
Which patent matters: drug substance, brand product, or formulation?
For semaglutide in Mexico, the expiry date you’re looking for could be tied to different kinds of IP:
- Patents on the underlying semaglutide molecule (often filed years earlier).
- Patents on a specific product/formulation (such as the injectable vs oral version).
- Patents on therapeutic use or manufacturing processes.
Each category can have a different term and may also be affected by how protection was filed and granted in Mexico.
How to find the exact Mexico expiry date reliably
To get the correct date, you typically need to check Mexico patent records for the specific assignee(s) and the exact product/active ingredient:
1. Identify the semaglutide brand name(s) and manufacturer(s) sold in Mexico (this points you to the relevant assignee/patent owner).
2. Search the Mexican patent database for patents covering semaglutide and those specific product claims.
3. Use the patent’s filing date and term rules (plus any adjustments) to determine the scheduled expiry.
Is it the same date for Ozempic vs Wegovy vs Rybelsus?
No. Even if they share semaglutide as the active ingredient, different products in different dosage forms can rely on different patents in Mexico, so expiry can vary by product.
If you tell me the brand or patent number, I can be more specific
If you share either (a) the brand name you mean (for example, Ozempic, Wegovy, or Rybelsus) or (b) the Mexican patent number (or assignee), I can help pin down the likely expiry date for that specific protection.
Sources: None cited (no patent database details were provided).